Publications
Filters: First Letter Of Title is O [Clear All Filters]
“Optimizing G6PD testing for Plasmodium vivax case management: why sex, counseling, and community engagement matter”, Wellcome Open Res, vol. 5, p. 21, 2020.
, “Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children”, Nat Commun, vol. 10, no. 1, p. 480, 2019.
, “Optimal Duration of Follow-up for Assessing Antimalarial Efficacy in Pregnancy: A Retrospective Analysis of a Cohort Followed Up Until Delivery on the Thailand-Myanmar Border”, Open Forum Infect Dis, vol. 6, no. 7, p. ofz264, 2019.
, “Open-source discovery of chemical leads for next-generation chemoprotective antimalarials”, ScienceScience, vol. 362, 2018.
, “Operational Performance of a Plasmodium falciparum Ultrasensitive Rapid Diagnostic Test for Detection of Asymptomatic Infections in Eastern Myanmar”, J Clin Microbiol, vol. 56, no. 8. 2018.
, “The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background”, Nat Commun, vol. 9, no. 1, p. 5158, 2018.
, “The overlap between miscarriage and extreme preterm birth in a limited-resource setting on the Thailand-Myanmar border: a population cohort study”, Wellcome Open Res, vol. 1. p. 32, 2018.
, “Obstetric ultrasound aids prompt referral of gestational trophoblastic disease in marginalized populations on the Thailand-Myanmar border”, Glob Health Action, vol. 10, no. 1, p. 1296727, 2017.
, “Optimal health and disease management using spatial uncertainty: a geographic characterization of emergent artemisinin-resistant Plasmodium falciparum distributions in Southeast Asia”, Int J Health Geogr, vol. 15, no. 1, p. 37, 2016.
, “Optimal health and disease management using spatial uncertainty: a geographic characterization of emergent artemisinin-resistant Plasmodium falciparum distributions in Southeast Asia”, International Journal of Health Geographics, vol. 15, no. 1, p. 37, 2016.
, “Overcoming Chloroquine Resistance in Malaria: Design, Synthesis and Structure-Activity Relationships of Novel Hybrid Compounds”, Antimicrob Agents Chemother, 2016.
, “Opposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation”, Br J Clin Pharmacol, vol. 80, no. 4, pp. 642-53, 2015.
, “Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives”, Malar J, vol. 12, no. 1, p. 411, 2013.
, “Other 4-Methanolquinolines, Amyl Alcohols and Phentathrenes: Mefloquine, Lumefantrine and Halofantrine”, in Treatment and Prevention of Malaria, Springer Basel, 2012, pp. 95-111.
, “An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia”, PLoS ONE, vol. 5, no. 7, p. e11880, 2010.
, “Obstetric ultrasound scanning by local health workers in a refugee camp on the Thai-Burmese border”, Ultrasound Obstet Gynecol, vol. 34, no. 4, pp. 395-403, 2009.
, “OC08.01: Quality assessment of fetal biometry in locally trained sonographers in a developing country setting”, Ultrasound in Obstetrics & Gynecology, vol. 34, no. S1, pp. 13-13, 2009.
, “Overestimating resistance in field testing of malaria parasites: simple methods for estimating high EC50 values using a Bayesian approach”, Malar J, vol. 6, no. 1, p. 4, 2007.
, “An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand”, Trop Med Int Health, vol. 11, no. 11, pp. 1653-60, 2006.
, “Optimising operational use of artesunate-mefloquine: a randomised comparison of four treatment regimens”, Trans R Soc Trop Med Hyg, vol. 98, no. 3, pp. 182-92, 2004.
, “Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 53, no. 5, pp. 522-5, 1995.
,